🇺🇸 FDA

Company profile · Sponsor

Suzhou

Suzhou Ribo Life Science Co.

CF1B291 · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Suzhou (CF1B291) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CF1B291
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. SHR-A2009 ; Aumolertinib

    Suzhou

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  2. Dose escalation of SA030

    Suzhou

    Obese

    phase 1 small molecule active

    1 trial

  3. RBD7022

    Suzhou

    Hyperlipemia

    phase 1 small molecule completed

    1 trial

  4. UTAA91 injection

    Suzhou

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial

Frequently asked questions

What is Suzhou?

Suzhou (CF1B291) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Suzhou sponsor?

We track 4 ClinicalTrials.gov-linked programs for Suzhou, including SHR-A2009 ; Aumolertinib and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Suzhou company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.